Forward Citations = 140

Loading Chart...

4 inventors (with patents filed for the assignee):

Shailendra K Saxena (12 out of 15 patents)

Wojciech J Ardelt (7 out of 12 patents)

Stanislaw M Mikulski (5 out of 5 patents)

4. Kuslima Shogen (1 out of 1 patent)

20 patents: Sort by Forward Citations

1. 7763449 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence that is at least one residue long (2010-07-27),

2. 7585655 - Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease (2009-09-08),

3. 7585654 - Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugated (2009-09-08),

4. 7556953 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an N-terminal leader sequence (2009-07-07),

5. 7556952 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of a known amino acid sequence and an initial N-terminal residue (2009-07-07),

6. 7556951 - Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long (2009-07-07),

7. 7473542 - Cysteinized ribonuclease and targeting moiety conjugated thereto (2009-01-06),

8. 7442536 - Cysteinized ribonuclease and targeting moiety conjugated thereto (2008-10-28),

9. 7442535 - Fusion protein incorporating a cysteinized ribonuclease (2008-10-28),

10. 7229824 - Ribonucleases and methods of making them recombinantly (2007-06-12),

11. 6423515 - Methods of making nucleic acids encoding ribonucleases (2002-07-23),

12. 6290951 - Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells (2001-09-18),

13. 6239257 - Family of proteins belonging to the pancreatic ribonuclease a superfamily (2001-05-29),

14. 6175003 - Nucleic acids encoding ribonucleases and methods of making them (2001-01-16),

15. 5728805 - Pharmaceuticals and method for making them (1998-03-17),

Company Overview

Alfacell Corporation is a biotechnology company based in Bloomfield, New Jersey, specializing in the development of innovative therapies for cancer treatment. The company focuses on the research and commercialization of RNA-based therapeutics, leveraging its expertise in molecular biology to create targeted treatments. Alfacell is dedicated to advancing medical science through its commitment to developing effective solutions for patients, aiming to improve outcomes in oncology and enhance the quality of life for those affected by cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

20 Patents

#5 in Bloomfield, NJ

#619 in New Jersey

#16,395 in US

#31,264 in the World

Bloomfield, NJ, United States of America

Alfacell Corporation

Forward Citations = 140

4 inventors:

Shailendra K Saxena (12 out of 15 patents)

Wojciech J Ardelt (7 out of 12 patents)

Stanislaw M Mikulski (5 out of 5 patents)

4. Kuslima Shogen (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alfacell Corporation. Retrieved from https://idiyas.com/company/alfacell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]